The purpose of this study is to evaluate the efficacy and safety of repeated doses of a low dosage of oromucosal Ibuprofen form (lozenge) versus placebo in patients suffering from acute sore throat pain.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Enrollment
427
Lozenge, Oromucosal administration
Lozenge matching V0498 lozenge, Oromucosal administration
Unnamed facility
Gières, France
Unnamed facility
Erfurt, Germany
Unnamed facility
Balvi, Latvia
Unnamed facility
Daugavpils, Latvia
Total Pain relief over 2 hours
Total Pain Relief (TOTPAR) assessed on a 7-point rating scale called the Sore Throat Relief Scale (STRS) over 120min after the start of sucking of 1st study drug administered
Time frame: 0-2 hours post-dose
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Unnamed facility
Jelgava, Latvia
Unnamed facility
Jēkabpils, Latvia
Unnamed facility
Kuldīga, Latvia
Unnamed facility
Liepāja, Latvia
Unnamed facility
Ogre, Latvia
Unnamed facility
Ogres Municipality, Latvia
...and 4 more locations